cpcvisual_edited.jpg

Active oral protection

for optimum health.

cpc.tp.png
corona2.png
3001LOGO VITIS .png

VITIS® CPC protect mouthwash & toothpaste

​

VITIS® CPC protect mouthwash & toothpaste are specially formulated for those seeking active oral protection for optimum health.

​

​

What is CPC ?

 

 

​

​

 

 

 

​

Cetylpyridinium Chloride (CPC) is a safe and effective daily-use antiseptic with antiplaque action and a substantivity of between 3 and 5 hours.

 
cpc.logo.png

Protect your mouth

now more than ever !

cpcprotectmask1000.png

Formulated with CPC to ensure active oral protection

​

  • People seeking active oral protection for optimum health.

  • Those seeking extra daily care protection.

  • Suitable for people suffering from coeliac disease.

How to use

  • People who are looking for active oral protection for an optimal health

  • People who are looking for extra protection in their daily care

  • Suitable for coeliacs

COMPOSITION

  • VITIS® CPC protect mouthwash is formulated with a 0.07% concentration of Cetylpyridinium chloride (CPC).

  • VITIS® CPC protect toothpaste: 0.14% CPC
    1450 ppm Sodium fluoride

ACTION

  • Protects and strengthens gums

  • Increase substantivity of CPC

  • Reinforces enamel

  • Reduces plaque (biofilm) build-up. Reduces virus particles; see Clinical trials related to Covid-19-Sars2. 

  • Daily-use anti-plaque that prevents the formation of
    dental plaque (biofilm) and helps reduce the accumulation thereof.18,19,20
    • Remineralises enamel and prevents dental caries.

75ml                           500ml
Reinforce your oral hygiene on a daily basis
alcoholfree1.png

ABC diseases

The mouthwash that deactivates the coronavirus

COVID-19 AND ITS RELATION WITH THE ORAL CAVITY

• How is the infection produced?
• The viral load and its relation to disease severity
• Transmission of SARS-CoV-2 in the dental clinic
• Conclusions

CETYLPYRIDINIUM CHLORIDE (CPC) AND SCIENTIFIC EVIDENCE AGAINST SARS-CoV-2

• CPC (Cetylpyridinium Chloride)
• Study by Popkin et al. 2017
• Study by Mukherjee et al. 2017
• Conclusions and prevention protocols

BIBLIOGRAPHY

1. Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al.High expression of ACE2
receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020
Feb 24;12(1):8.
2. Rabi FA, Al Zoubi MS, Kasasbeh GA, Salameh DM, Al-Nasser AD. SARS-CoV-2 and
Coronavirus Disease 2019: What We Know So Far. Pathogens. 2020 Mar 20;9(3)
3. Wölfel R. Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al.
Virological assessment of hospitalized patients with COVID-2019. Nature https://-
doi.org/10.1038/s41586-020-2196-x (2020).
4. Peng X, Xu X, Li Y, Cheng L, Zhou X, Ren B. Transmission routes of 2019-nCoV
and controls in dental practice. Int J Oral Sci. 2020 Mar 3;12(1):9
5. Liu Y, Yan LM, Wan L, Xiang TX, Le A, Liu JM, Peiris M, Poon LLM, Zhang W. Viral
dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020 Mar 19.
pii: S1473-3099(20)30232-

6. Popkin DL,ZilkaS,DimaanoM, Fujioka H, Rackley C,SalataR et al.Cetylpyridinium
chloride (CPC) exhibits potent, rapid activitygainstinfluenza viruses in
vitro and in vivo.PathogensandImmunity. 2017;2(2):253-69.
7. Mukherjee PK, Esper F, Buchheit K, Arters K, Adkins I, Ghannoum MAet al.
Randomized, double-blind, placebo-controlled clinical trial to assess the safety
and effectiveness of a novel dual-action oral topical formulation against upper
respiratory infections. BMC Infect Dis. 2017 Jan 14;17(1):74
8. Liang Shen, Junwei Niu, Chunhua Wang, Baoying Huang, Wenling Wang, Na
Zhu, Yao Deng, Huijuan Wang, Fei Ye, Shan Cen, Wenjie Tan. 2019. High-Throughput
Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
Journal of Virology. doi: 10.1128/JVI.00023-19 93 (12)
9. Quirynen M, Avontroodt P, Soers C, Zhao H, Pauwels M, van Steenberghe D.
Impact of tongue cleansers on microbial load and taste. J Clin Periodontol 2004;
31: 506–510.